Paycheck Protection Program Loan (Details Narrative) (Supera Pharmaceuticals, Inc.) - Supera Pharmaceuticals, Inc. [Member] - USD ($) |
1 Months Ended | 12 Months Ended | |
|---|---|---|---|
Apr. 30, 2020 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Proceeds from loan | $ 16,600 | ||
| Maximum [Member] | |||
| Loans | $ 2,000,000 | ||
| Paycheck Protection Program Loan [Member] | |||
| Proceeds from loan | $ 16,600 | ||
| Debt term | 2 years | ||
| Debt interest rate | 1.00% | ||
| Loan audit inspection description | the SBA and other government communications have indicated that all loans in excess of $2 million including loans with affiliates will be subject to audit and that those audits could take up to seven years to complete. | ||
| X | ||||||||||
- Definition Loan audit inspection description. No definition available.
|
| X | ||||||||||
- Definition Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|